We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new brain imaging clinical trial funded by the National Institutes of Health (NIH) has showed that multiple sclerosis drug ibudilast was better than a placebo at slowing down brain shrinkage.